Proposed Data Collection Submitted for Public Comment and Recommendations, 53305-53306 [2021-20845]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Center
for Preparedness and Response, (BSC,
CPR)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Center for Preparedness and Response,
(BSC, CPR). This is a virtual meeting
that is open to the public, limited only
by the number of internet conference
accesses available, which is 500. Preregistration is required by accessing the
link in the ADDRESSES section.
DATES: The meeting will be held on
November 2, 2021, from 12:30 p.m. to
4:30 p.m., EDT.
ADDRESSES: Zoom Virtual Meeting. If
you wish to attend the virtual meeting,
please pre-register by accessing the link
at: https://cdc.zoomgov.com/webinar/
register/WN_
ozgFewBJSXCWfEXwqrA2cw.
Instructions to access the Zoom virtual
meeting will be provided in the link
following registration.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop—H21–6,
Atlanta, Georgia 30329–4027,
Telephone: (404) 639–7450; Facsimile:
(678) 669–1667; Email: DOuisley@
cdc.gov.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
Purpose: The Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Center for Preparedness and Response
(CPR), concerning strategies and goals
for the programs and research within
CPR, monitoring the overall strategic
direction and focus of the CPR Divisions
and Offices, and administration and
oversight of peer review for CPR
scientific programs. For additional
information about the Board, please
visit: https://www.cdc.gov/cpr/bsc/
index.htm.
Matters To Be Considered: The agenda
will include: (1) CPR Director Update;
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
(2) CPR Division Updates and
Discussion; (3) COVID–19 Response
Update; (4) The Data Strategy and
Execution Workgroup: An Interagency
Approach to Coordinating Data and
Analytics Efforts to Support the Wholeof Government COVID–19 Response;
and (5) CPR Polio Containment
Workgroup (PCWG) Update. Agenda
items are subject to change as priorities
dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–20928 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0338; Docket No. CDC–2021–
0101]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Annual Submission of the
Ingredients Added to, and the Quantity
of Nicotine Contained in, Smokeless
Tobacco Manufactured, Imported, or
Packaged in the U.S. This Extension
permits CDC to collect a list of
ingredients added to tobacco in the
manufacture of smokeless tobacco
products, and a specification of the
quantity of nicotine contained in each
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
53305
product. CDC’s Office of Smoking and
Health (OSH) has been delegated with
the responsibility for implementing the
required information collection by HHS.
DATES: CDC must receive written
comments on or before November 26,
2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0101 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
E:\FR\FM\27SEN1.SGM
27SEN1
53306
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
the U. S. (OMB Control No. 0920–0338,
Exp. 4/30/2022)—Extension—National
Center for Chronic Disease and Public
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are
associated with many health problems.
Using smokeless tobacco: Can lead to
nicotine addiction; causes cancer of the
mouth, esophagus, and pancreas; is
associated with diseases of the mouth;
can increase risks for early delivery and
required information to CDC through a
designated representative. The
information collection is subject to strict
confidentiality provisions.
Ingredient and nicotine analysis
reports for new SLT products are due at
the time of first importation. Thereafter,
ingredient reports are due annually on
March 31. Information is submitted to
CDC by mailing a written report on the
respondent’s letterhead. Electronic mail
submissions are not accepted. Annual
submission reports are mailed to
Attention: FCLAA Program Manager,
Office on Smoking and Health, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway NE, MS S107–7,
Atlanta, GA 30341–3717.
Following receipt of the annual
nicotine and ingredient report, CDC
issues a Certificate of Compliance to the
respondent. As deemed appropriate by
the Secretary of HHS, HHS is authorized
to use the information to report to
Congress the health effects of
ingredients, research activities related to
the health effects of ingredients, and
other information that the Secretary
determines to be of public interest.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
18,843. OMB approval is requested for
three years.
stillbirth when used during pregnancy;
can cause nicotine poisoning in
children; and may increase the risk for
death from heart disease and stroke.
The CDC’s Office on Smoking and
Health (OSH) is the lead federal agency
for comprehensive tobacco prevention
and control. As required by the
Comprehensive Smokeless Tobacco
Health Education Act of 1986 (CSTHEA,
15 U.S.C. 4401 et seq., Pub. L. 99–252),
CDC collects a list of ingredients added
to tobacco in the manufacture of
smokeless tobacco products and a
specification of the quantity of nicotine
contained in each product. HHS has
delegated responsibility for
implementing the required information
collection to CDC’s OSH. Respondents
are manufacturers, packagers, or
importers (or their representatives) of
smokeless tobacco products.
Respondents are not required to submit
specific forms; however, they are
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies that are
required to report ingredients added to
other consumer products, and to report
on the quantity of nicotine contained in
each smokeless tobacco product as
specified in previous Federal Register
Notices. Respondents may submit the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Smokeless Tobacco Manufacturers, Packagers, and Importers.
Smokeless Tobacco Manufacturers, Packagers, and Importers.
SLT Ingredient Report .............
11
1
6.5
71.5
SLT Nicotine Data Reporting ..
11
1
1,706.5
18,771.5
Total ....................................................
..................................................
........................
........................
........................
18,843
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–20845 Filed 9–24–21; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[Docket No. CDC–2021–0106; NIOSH–344]
Interventions To Prevent Work-Related
Stress and Support Health Worker
Mental Health; Request for Information
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
Centers for Disease Control and
Prevention, HHS.
ACTION: Request for information.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH), within the Centers for Disease
SUMMARY:
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Control and Prevention (CDC),
announces an opportunity for the public
to provide information and comments
on current evidence-based, workplace
and occupational safety and health
interventions to prevent workassociated stress, support stress
reduction, and foster positive mental
health and well-being among the
nation’s health workers. Information
and comments are also requested on
interventions under development and
research in progress to support and
promote the mental health and wellbeing of health workers. NIOSH is
seeking information on related best
practices, promising practices, or
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53305-53306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20845]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0338; Docket No. CDC-2021-0101]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Annual Submission of the
Ingredients Added to, and the Quantity of Nicotine Contained in,
Smokeless Tobacco Manufactured, Imported, or Packaged in the U.S. This
Extension permits CDC to collect a list of ingredients added to tobacco
in the manufacture of smokeless tobacco products, and a specification
of the quantity of nicotine contained in each product. CDC's Office of
Smoking and Health (OSH) has been delegated with the responsibility for
implementing the required information collection by HHS.
DATES: CDC must receive written comments on or before November 26,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0101 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information,
[[Page 53306]]
including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Annual Submission of the Ingredients Added to, and the Quantity of
Nicotine Contained in, Smokeless Tobacco Manufactured, Imported, or
Packaged in the U. S. (OMB Control No. 0920-0338, Exp. 4/30/2022)--
Extension--National Center for Chronic Disease and Public Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are associated with many health
problems. Using smokeless tobacco: Can lead to nicotine addiction;
causes cancer of the mouth, esophagus, and pancreas; is associated with
diseases of the mouth; can increase risks for early delivery and
stillbirth when used during pregnancy; can cause nicotine poisoning in
children; and may increase the risk for death from heart disease and
stroke.
The CDC's Office on Smoking and Health (OSH) is the lead federal
agency for comprehensive tobacco prevention and control. As required by
the Comprehensive Smokeless Tobacco Health Education Act of 1986
(CSTHEA, 15 U.S.C. 4401 et seq., Pub. L. 99-252), CDC collects a list
of ingredients added to tobacco in the manufacture of smokeless tobacco
products and a specification of the quantity of nicotine contained in
each product. HHS has delegated responsibility for implementing the
required information collection to CDC's OSH. Respondents are
manufacturers, packagers, or importers (or their representatives) of
smokeless tobacco products. Respondents are not required to submit
specific forms; however, they are required to meet reporting guidelines
and to submit the ingredient report by chemical name and Chemical
Abstract Service (CAS) Registration Number, consistent with accepted
reporting practices for other companies that are required to report
ingredients added to other consumer products, and to report on the
quantity of nicotine contained in each smokeless tobacco product as
specified in previous Federal Register Notices. Respondents may submit
the required information to CDC through a designated representative.
The information collection is subject to strict confidentiality
provisions.
Ingredient and nicotine analysis reports for new SLT products are
due at the time of first importation. Thereafter, ingredient reports
are due annually on March 31. Information is submitted to CDC by
mailing a written report on the respondent's letterhead. Electronic
mail submissions are not accepted. Annual submission reports are mailed
to Attention: FCLAA Program Manager, Office on Smoking and Health,
National Center for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS
S107-7, Atlanta, GA 30341-3717.
Following receipt of the annual nicotine and ingredient report, CDC
issues a Certificate of Compliance to the respondent. As deemed
appropriate by the Secretary of HHS, HHS is authorized to use the
information to report to Congress the health effects of ingredients,
research activities related to the health effects of ingredients, and
other information that the Secretary determines to be of public
interest.
There are no costs to respondents other than their time. The total
estimated annualized burden hours are 18,843. OMB approval is requested
for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Smokeless Tobacco SLT Ingredient 11 1 6.5 71.5
Manufacturers, Packagers, and Report.
Importers.
Smokeless Tobacco SLT Nicotine 11 1 1,706.5 18,771.5
Manufacturers, Packagers, and Data Reporting.
Importers.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 18,843
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-20845 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P
